Related Experiment Video
Updated: Jan 23, 2026

Surgically Induced Cardiac Volume Overload by Aortic Regurgitation in Mouse
Published on: August 30, 2022
Depolysulfidation of Drp1 induced by low-dose methylmercury exposure increases cardiac vulnerability to hemodynamic
Akiyuki Nishimura1,2,3, Kakeru Shimoda2,3,4, Tomohiro Tanaka2,3,5
1Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Abstract:
Chronic exposure to methylmercury (MeHg), an environmental electrophilic pollutant, reportedly increases the risk of human cardiac events. We report that exposure to a low, non-neurotoxic dose of MeHg precipitated heart failure induced by pressure overload in mice. Exposure to MeHg at 10 ppm did not induce weight loss typical of higher doses but caused mitochondrial hyperfission in myocardium through the activation of Drp1 by its guanine nucleotide exchange factor filamin-A. Treatment of neonatal rat cardiomyocytes with cilnidipine, an inhibitor of the interaction between Drp1 and filamin-A, suppressed mitochondrial hyperfission caused by low-dose MeHg exposure. Modification of cysteine residues in proteins with polysulfides is important for redox signaling and mitochondrial homeostasis in mammalian cells. We found that MeHg targeted rat Drp1 at Cys624, a redox-sensitive residue whose SH side chain forms a bulky and nucleophilic polysulfide (Cys624-S(n)H). MeHg exposure induced the depolysulfidation of Cys624-S(n)H in Drp1, which led to filamin-dependent activation of Drp1 and mitochondrial hyperfission. Treatment with NaHS, which acts as a donor for reactive polysulfides, reversed MeHg-evoked Drp1 depolysulfidation and vulnerability to mechanical load in rodent and human cardiomyocytes and mouse hearts. These results suggest that depolysulfidation of Drp1 at Cys624-S(n)H by low-dose MeHg increases cardiac fragility to mechanical load through filamin-dependent mitochondrial hyperfission.
Insights
Low-dose methylmercury (MeHg) exposure causes heart failure by disrupting mitochondrial dynamics in cardiac cells. This environmental pollutant triggers depolysulfidation of Drp1, leading to heart muscle fragility under mechanical stress.
Area of Science:
- Biochemistry
- Toxicology
- Cardiology
Background:
- Chronic methylmercury (MeHg) exposure is linked to increased cardiac event risk.
- Low, non-neurotoxic MeHg doses can precipitate heart failure under pressure overload.
- Mitochondrial dysfunction plays a key role in heart failure pathogenesis.
Purpose of the Study:
- To investigate the mechanism by which low-dose MeHg induces heart failure.
- To identify the specific molecular targets of MeHg in cardiac mitochondria.
- To explore potential therapeutic interventions against MeHg-induced cardiotoxicity.
Main Methods:
- Mice were exposed to a low dose of MeHg (10 ppm) and subjected to pressure overload.
- Cardiomyocytes were treated with MeHg and specific inhibitors (cilnidipine, NaHS).
- Mitochondrial morphology, Drp1 activation, and protein polysulfidation were analyzed.
Main Results:
- Low-dose MeHg induced mitochondrial hyperfission in myocardium via Drp1 activation.
- MeHg targeted and caused depolysulfidation of Drp1 at Cys624.
- NaHS treatment reversed MeHg-induced depolysulfidation and cardiac vulnerability.
Conclusions:
- MeHg-induced depolysulfidation of Drp1 at Cys624 increases cardiac fragility.
- Filamin-A mediates MeHg-induced Drp1 activation and mitochondrial hyperfission.
- Restoring polysulfidation may protect against MeHg cardiotoxicity.
More Related Videos
09:24O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy
Published on: October 6, 2022
08:51Multiple Intravenous Bolus Dosing and Invasive Hemodynamic Assessment in a Hypoxia-Induced Mouse Pulmonary Artery Hypertension Model
Published on: November 11, 2022
Related Concept Videos
Dose Size and Dosing Frequency: Determination Methods
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
Increased Body Temperature
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Dose-Response Relationship: Overview